Mortality and Morbidity Associated With New Onset Acute Kidney Injury in Critically Ill COVID-19 Infection Patients
1 other identifier
observational
267
1 country
1
Brief Summary
This study explored the incidence of morbidity and mortality associated with AKI in critically ill adult patients infected with COVID-19. There are two groups for comparison. Group1. patients were directly admitted to the intensive care unit (ICU) from the emergency department (ED) Group 2. patients were initially managed on the medical floor and later transferred to the ICU for worsening respiratory status. The investigating team evaluated the correlation of inflammatory markers and common risk factors such as obesity, diabetes, hypertension and ethnicity to the development of AKI in the target population. The primary outcome is mortality participants will received their regular healthcare in a medical setting
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 12, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 12, 2022
CompletedFirst Submitted
Initial submission to the registry
July 24, 2023
CompletedFirst Posted
Study publicly available on registry
July 27, 2023
CompletedJuly 27, 2023
July 1, 2023
2 years
July 24, 2023
July 25, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Mortality
mortality at hospital discharge
from admission until death from any cause, whichever comes first, assessed up to three months
Study Arms (2)
Group1
These critically ill patients were directly admitted to the intensive care unit from the emergency department
Group 2
These critically ill patients were were initially managed on the medical floor and later transferred to the intensive care unit for worsening respiratory status
Eligibility Criteria
This is a two-year retrospective study of critically ill adult patients infected with COVID-19 that were admitted to the intensive care unit on ventilatory support. Patients included in this study were admitted to Arrowhead Regional Medical Center (ARMC) from March 1, 2020 to February 12, 2022.
You may qualify if:
- positive for SARS-CoV-2 on a real-time polymerase chain reaction test (RT-PCR) upon admission to the hospital
You may not qualify if:
- chronic kidney disease end stage renal disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Arrowhead Regional Medical Center
Colton, California, 92324, United States
Related Publications (1)
Fischer N, Miao X, Weck D, Matalon J, Neeki CC, Pennington T, Dong F, Arabian S, Neeki MM. Mortality and morbidity associated with new onset acute kidney injury in critically ill COVID-19 infection patients. Int J Emerg Med. 2024 Jul 29;17(1):97. doi: 10.1186/s12245-024-00666-6.
PMID: 39075369DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael M Neeki, DO
Arrowhead Regional Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending Physician
Study Record Dates
First Submitted
July 24, 2023
First Posted
July 27, 2023
Study Start
March 1, 2020
Primary Completion
February 12, 2022
Study Completion
February 12, 2022
Last Updated
July 27, 2023
Record last verified: 2023-07